When science, technology and research meet, something unique is born.
In 2015 IBSA Derma brought an innovative, concrete solution for the signs of ageing to the aesthetic medicine sector: a new way to look after yourself and your skin, not changing your appearance but celebrating your own uniqueness.
Hyaluronic acid is a molecule found naturally in the body: it is vital for hydrating the skin, keeping it toned and elastic and boosting regeneration and repair.
In 2015 IBSA Derma patented a thermal process that combines high and low molecular weight hyaluronic acid chains, without using chemical reagents. This produces cooperative hybrid complexes of hyaluronic acid in high concentrations. All this lies at the core of NAHYCO® Hybrid Technology.
The hybrid complexes obtained via NAHYCO® Hybrid Technology – 100% free from cross-linking chemical agents – are more resistant to deterioration than linear hyaluronic acid, with longer-lasting effects. This high-tech innovation helps visibly combat the signs of ageing, improving the skin’s firmness, tone and elasticity.
NAHYCO® Hybrid Technology forms the innovative core of bioremodeling, an advanced, regenerative aesthetic medicine treatment that kick-starts the skin’s natural biological processes, helping regenerate the tissues. The unique molecular complexes used in NAHYCO® work deep-down, stimulating collagen and elastin production and improving skin renewal. Talking about bioremodeling means targeting different layers of the tissues: combating sagging skin and enhancing its firmness, tone and elasticity.
The patented technology combines high molecular weight (H-HA) and low molecular weight (L-HA) hyaluronic acid using an innovative 4-step process:
